Model
Edge
Navidea Biopharmaceuticals, Inc.
NAVB
Filing Type
DEF 14A
Filing Date
7/2/2023
Updated
7/3/23, 11:30 AM
Filing
DEF 14A
Earnings Release
Exhibits
DEF 14A
Definitive Proxy Statement